Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

Larysa Fedchuk, Fabio Nascimbeni, R. Pais, +3

Alimentary Pharmacology & Therapeutics

Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standard

Thierry Poynard, M. Munteanu, Elena Luckina, +10

Journal of Hepatology

Gold StandardMedical UltrasoundHepatologyMedical ImagingLiver Fibrosis Evaluation +12

Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease

Fabio Nascimbeni, Pierre Bédossa, Larysa Fedchuk, +5

Journal of Hepatology

Flip AlgorithmClinical ValidationFatty Liver DiseaseObesityMetabolic Syndrome +14

Significant Variations in Elastometry Measurements Made Within Short-term in Patients With Chronic Liver Diseases

Fabio Nascimbeni, Pascal Lebray, Larysa Fedchuk, +9

Clinical Gastroenterology and Hepatology

Significant VariationsBody CompositionHepatologyMeasurementLiver Physiology +9

Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme

Christophe Hézode, Pascal Lebray, Victor de Lédinghen, +20

Liver International

LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use program

Christophe Hézode, Victor de Lédinghen, H. Fontaine, +19

Journal of Hepatology

Hcv Genotype 3Interim AnalysisViral HepatitisAntiviral Drug DevelopmentAntiviral Therapy +8

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

Karine Lacombe, Hélène Fontaine, Catherine Dhiver, +26

JAIDS Journal of Acquired Immune Deficiency Syndromes

Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program

Christophe Hézode, Victor de Lédinghen, Hélène Fontaine, +19

HAL (Le Centre pour la Communication Scientifique Directe)

Sustained Virologic Response to Daclatasvir and Sofosbuvir, with or without Ribavirin, among Patients in the French Daclatasvir ATU Programme Infected with HCV Genotypes 4, 5 and 6

Christophe Hézode, Armand Abergel, J. Chas, +16

Journal of Hepatology

Hcv Genotypes 4Viral PersistenceHepatitis CViral HepatitisAntiviral Therapy +7

Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: A retrospective repeated liver biopsy analysis

Patrick Ingiliz, Marc‐Antoine Valantin, Paul Preziosi, +7

Journal of Hepatology

ImmunologyPathologyCirrhosisAutoimmune Liver DiseaseViral Hepatitis +14